June 23, 2017 Neos Therapeutics Announces FDA Approval of Extended-Release Orally Disintegrating Tablets June 23, 2017 Neos Therapeutics, Inc. recently announced that the US FDA approved Cotempla XR-ODT, the first and only methylphenidate extended-release orally disintegrating...